Registry for patients undergoing transcatheter tricuspid valve interventions
International Multisite Transcatheter Tricuspid Valve Therapies Registry
University of Zurich · NCT03416166
This study is collecting information from patients who are getting a new type of heart procedure for severe tricuspid valve problems to help improve future treatments and guidelines.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 269 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University of Zurich (other) |
| Locations | 1 site (Zurich) |
| Trial ID | NCT03416166 on ClinicalTrials.gov |
What this trial studies
This registry collects clinical and anatomical data from patients undergoing transcatheter tricuspid valve interventions for severe tricuspid regurgitation. It aims to enhance understanding of the epidemiology and outcomes associated with these therapies, which have gained attention as alternatives for high-risk patients. By documenting patient outcomes, the registry seeks to inform future guidelines and improve treatment approaches in this area of cardiac care.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients aged 18 and older who are undergoing transcatheter tricuspid valve interventions.
Not a fit: Patients who do not meet the indications for transcatheter tricuspid intervention will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment guidelines and outcomes for patients with severe tricuspid regurgitation.
How similar studies have performed: While the specific approach of this registry is novel, there is growing interest and some success in similar transcatheter interventions for other heart valve diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All the patients undergoing transcatheter tricuspid valve intervention. General inclusion criteria: * Minimal age: 18 years * Patient is able to give written informed consent to the procedure Exclusion Criteria: * Patients not fulfilling the indications for transcatheter tricuspid intervention
Where this trial is running
Zurich
- University Hospital Zurich — Zurich, Switzerland (RECRUITING)
Study contacts
- Study coordinator: Maurizio Taramasso, MD, PhD
- Email: maurizio.taramasso@usz.ch
- Phone: 0041442553728
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Severe Tricuspid Regurgitation, Tricuspid Valve, tricuspid regurgitation, transcatheter tricuspid regurgitation